Director Lab General Biochemistry & Physical Pharmacy
Department of Pharmaceutics - Ghent University - Belgium
Gent, Belgium
Professor Stefaan De Smedt is the founder and director of the Ghent Research Group on Nanomedicines from Ghent University (Belgium). The research focus in his lab is on the delivery of bio-therapeutics, nucleic acids and proteins, for future therapies of lung and ocular diseases and cancer (through mRNA vaccination and cell therapies). Together with partners in academia and industry his lab develops and evaluates delivery concepts and technologies for novel advanced therapies.
He has been a Guest Professor at various universities in Belgium, China and Italy. Since 2004 he serves as the European Editor of the JCR; Since 2023 he is leading the JCR as Editor-in-Chief. He has been elected as member of the Flemish Royal Academy of Medicine, the European Academy of Sciences and the Académie Nationale de Pharmacie de France.
Disclosure information not submitted.
Tech Session III: Manufacturing and Process Scale-Up
Wednesday, July 16, 2025
10:00 AM - 12:00 PM EDT
